| 
               [X] 
             | 
            
               QUARTERLY
      REPORT PURSUANT TO SECTION 13 OR 15(d) 
              OF
      THE SECURITIES EXCHANGE ACT OF 1934 
             | 
          
| 
               [  ] 
             | 
            
               TRANSITION
      REPORT PURSUANT TO SECTION 13 OR 15(d) 
              OF
      THE SECURITIES EXCHANGE ACT OF 1934 
             | 
          
| 
               Delaware 
              (State
      or other jurisdiction of 
              incorporation
      or organization) 
             | 
            
               57-0426694 
              (IRS
      Employer 
              Identification
      Number) 
             | 
          |
| 
               2155
      West Croft Circle 
              Spartanburg,
      South Carolina 
              (Address
      of principal executive offices) 
             | 
            
               29302 
              (Zip
      code) 
             | 
          
| 
               | 
          
| 
               (Registrant's
      telephone number, including area code)
 
             | 
          
| 
               Larger
      accelerated filer (  ) 
             | 
            
               Accelerated
      filer (X)  
             | 
          
| 
               Non-accelerated
      filer (  ) (Do
      not check if a smaller reporting company) 
             | 
            
               Smaller
      reporting
company  (  ) 
             | 
          
| PART I. | FINANCIAL INFORMATION | 
| 
                Item
      1. 
             | 
            
               Financial
      Statements (unaudited) 
             | 
          
| 
               Condensed
      consolidated balance sheets - March 29, 2008 and December 29,
      2007 
             | 
          |
| 
               Condensed
      consolidated statements of income - Three months ended March 29, 2008
      and 
              March
      31, 2007 
             | 
          |
| 
               Condensed
      consolidated statements of cash flows - Three months ended March 29, 2008
      and 
              March
      31, 2007 
             | 
          |
| 
               Notes
      to condensed consolidated financial statements - March 29,
      2008 
             | 
          |
| 
               Item
      2. 
             | 
            
               Management's
      Discussion and Analysis of Financial Condition and Results of
      Operations 
             | 
          
| 
               Item
      3. 
             | 
            
               Quantitative
      and Qualitative Disclosures About Market Risk 
             | 
          
| 
               Item
      4. 
             | 
            
               Controls
      and Procedures 
             | 
          
| PART II. | OTHER INFORMATION | 
| 
               Item
      1A. 
             | 
            
               Risk
      Factors 
             | 
          
| 
               Item
      2. 
             | 
            
               Unregistered
      Sales of Equity Securities and Use of Proceeds 
             | 
          
| 
               Item
      6. 
             | 
            
               Exhibits 
             | 
          
| 
               Signatures
      and Certifications 
             | 
          
| 
               Item
      1. FINANCIAL STATEMENTS 
             | 
            |||||||||||
| 
               Synalloy
      Corporation 
             | 
            |||||||||||
| 
               Condensed
      Consolidated Balance Sheets 
             | 
             
      
               Mar
      29, 2008 
             | 
            
               Dec
      29, 2007 
               | 
            |||||||||
| 
                (Unaudited) 
             | 
            
               (Note) 
             | 
            ||||||||||
| 
               Assets 
             | 
            |||||||||||
| 
               Current
      assets 
             | 
            |||||||||||
| 
               Cash
      and cash equivalents 
             | 
            $ | 25,936 | $ | 28,269 | |||||||
| 
               Accounts
      receivable, less allowance 
             | 
            |||||||||||
| 
               for
      doubtful accounts 
             | 
            27,834,141 | 19,887,556 | |||||||||
| 
               Inventories 
             | 
            |||||||||||
| 
               Raw
      materials 
             | 
            12,399,573 | 9,218,395 | |||||||||
| 
               Work-in-process 
             | 
            21,502,184 | 28,824,639 | |||||||||
| 
               Finished
      goods 
             | 
            12,228,426 | 10,758,064 | |||||||||
| 
               Total
      inventories 
             | 
            46,130,183 | 48,801,098 | |||||||||
| 
               Deferred
      income taxes 
             | 
            2,424,949 | 2,284,000 | |||||||||
| 
               Prepaid
      expenses and other current assets 
             | 
            321,808 | 433,250 | |||||||||
| 
               Total
      current assets 
             | 
            76,737,017 | 71,434,173 | |||||||||
| 
               Cash
      value of life insurance 
             | 
            2,817,500 | 2,805,500 | |||||||||
| 
               Property,
      plant & equipment, net of accumulated 
             | 
            |||||||||||
| 
               depreciation
      of $41,103,000 and $40,374,000 
             | 
            21,261,580 | 20,858,606 | |||||||||
| 
               Deferred
      charges and other assets 
             | 
            1,510,457 | 1,523,021 | |||||||||
| 
               Total
      assets 
             | 
            $ | 102,326,554 | $ | 96,621,300 | |||||||
| 
               Liabilities
      and Shareholders' Equity 
             | 
            |||||||||||
| 
               Current
      liabilities 
             | 
            |||||||||||
| 
               Current
      portion of long-term debt 
             | 
            $ | 466,667 | $ | 466,667 | |||||||
| 
               Accounts
      payable 
             | 
            13,100,747 | 13,029,172 | |||||||||
| 
               Accrued
      expenses 
             | 
            9,103,907 | 10,772,331 | |||||||||
| 
               Current
      portion of environmental reserves 
             | 
            512,018 | 467,371 | |||||||||
| 
               Income
      taxes payable 
             | 
            749,841 | - | |||||||||
| 
               Total
      current liabilities 
             | 
            23,933,180 | 24,735,541 | |||||||||
| 
               Long-term
      debt 
             | 
            16,270,500 | 10,246,015 | |||||||||
| 
               Environmental
      reserves 
             | 
            580,000 | 580,000 | |||||||||
| 
               Deferred
      compensation 
             | 
            399,475 | 409,462 | |||||||||
| 
               Deferred
      income taxes 
             | 
            2,637,000 | 2,510,000 | |||||||||
| 
               Shareholders'
      equity 
             | 
            |||||||||||
| 
               Common
      stock, par value $1 per share - authorized 
             | 
            |||||||||||
| 
               12,000,000
      shares; issued 8,000,000 shares 
             | 
            8,000,000 | 8,000,000 | |||||||||
| 
               Capital
      in excess of par value 
             | 
            555,065 | 532,860 | |||||||||
| 
               Retained
      earnings 
             | 
            65,409,689 | 65,113,597 | |||||||||
| 
               Less
      cost of Common Stock in treasury: 
             | 
            |||||||||||
| 
               1,757,259
      and 1,762,695 shares 
             | 
            (15,458,355 | ) | (15,506,175 | ) | |||||||
| 
               Total
      shareholders' equity 
             | 
            58,506,399 | 58,140,282 | |||||||||
| 
               Total
      liabilities and shareholders' equity 
             | 
            $ | 102,326,554 | $ | 96,621,300 | |||||||
| 
               Note:
      The balance sheet at December 29, 2007 has been derived from the audited
      consolidated financial statements at that date. 
             | 
          |||||||||||
| 
               See
      accompanying notes to condensed consolidated financial
      statements. 
             | 
            |||||||||||
| 
               Synalloy
      Corporation 
             | 
            ||||||||
| 
               Condensed
      Consolidated Statements of Income 
             | 
            ||||||||
| 
               (Unaudited) 
             | 
            ||||||||
| 
               Three
      Months Ended 
             | 
            ||||||||
| 
               Mar
      29, 2008 
             | 
            
               Mar
      31, 2007 
             | 
            |||||||
| 
               Net
      sales 
             | 
            $ | 50,974,023 | $ | 44,398,288 | ||||
| 
               Cost
      of goods sold 
             | 
            44,674,826 | 35,578,911 | ||||||
| 
               Gross
      profit 
             | 
            6,299,197 | 8,819,377 | ||||||
| 
               Selling,
      general and administrative expense 
             | 
            3,154,961 | 3,344,809 | ||||||
| 
               Operating
      income 
             | 
            3,144,236 | 5,474,568 | ||||||
| 
               Other
      (income) and expense 
             | 
            ||||||||
| 
                 Interest
      expense 
             | 
            332,279 | 208,803 | ||||||
| 
                 Other,
      net 
             | 
            (2,429 | ) | (1,029 | ) | ||||
| 
               Income
      before income taxes 
             | 
            2,814,386 | 5,266,794 | ||||||
| 
               Provision
      for income taxes 
             | 
            952,000 | 1,742,000 | ||||||
| 
               Net
      income 
             | 
            $ | 1,862,386 | $ | 3,524,794 | ||||
| 
               Net
      income per common share: 
             | 
            ||||||||
| 
               Basic 
             | 
            $ | .30 | $ | .57 | ||||
| 
               Diluted 
             | 
            $ | .30 | $ | .56 | ||||
| 
               Weighted
      average shares outstanding: 
             | 
            ||||||||
| 
               Basic 
             | 
            6,239,976 | 6,162,110 | ||||||
| 
                 Dilutive
      effect from stock 
             | 
            ||||||||
| 
                   options
      and grants 
             | 
            41,083 | 132,443 | ||||||
| 
               Diluted 
             | 
            6,281,059 | 6,294,553 | ||||||
| 
               See
      accompanying notes to condensed consolidated financial
      statements. 
             | 
            ||||||||
| 
               Condensed
      Consolidated Statements of Cash Flows 
             | 
            |||||||||
| 
               (Unaudited) 
             | 
            
               Three
      Months Ended 
             | 
          ||||||||
| 
                Mar
      29, 2008 
             | 
            Mar 31, 2007 | ||||||||
| 
               Operating
      activities 
             | 
            |||||||||
| 
                Net
      income 
             | 
            $ | 1,862,386 | $ | 3,524,794 | |||||
| 
                Adjustments
      to reconcile net income to net cash 
             | 
            |||||||||
| 
                   (used
      in) provided by operating activities: 
             | 
            |||||||||
| 
                   Depreciation
      expense 
             | 
            777,406 | 767,533 | |||||||
| 
                   Amortization
      of deferred charges 
             | 
            12,564 | 13,731 | |||||||
| 
                   Deferred
      income taxes 
             | 
            (5,898 | ) | (504,000 | ) | |||||
| 
                   Provision
      for losses on accounts receivable 
             | 
            149,407 | 117,467 | |||||||
| 
                   Gain
      on sale of property, plant and equipment 
             | 
            (1,200 | ) | - | ||||||
| 
                   Cash
      value of life insurance 
             | 
            (12,000 | ) | (12,000 | ) | |||||
| 
                   Environmental
      reserves 
             | 
            44,647 | (1,573 | ) | ||||||
| 
                   Employee
      stock option and grant compensation 
             | 
            51,655 | 33,641 | |||||||
| 
                   Changes
      in operating assets and liabilities: 
             | 
            |||||||||
| 
                       Accounts
      receivable 
             | 
            (8,095,992 | ) | (124,322 | ) | |||||
| 
                       Inventories 
             | 
            2,670,915 | 2,363,402 | |||||||
| 
                       Other
      assets and liabilities 
             | 
            (96,933 | ) | (28,283 | ) | |||||
| 
                       Accounts
      payable 
             | 
            71,575 | (1,463,054 | ) | ||||||
| 
                       Accrued
      expenses 
             | 
            (1,668,424 | ) | 675,887 | ||||||
| 
                       Income
      taxes payable 
             | 
            940,178 | 725,563 | |||||||
| 
               Net
      cash (used in) provided by operating activities 
             | 
            (3,299,714 | ) | 6,088,786 | ||||||
| 
               Investing
      activities 
             | 
            |||||||||
| 
                   Purchases
      of property, plant and equipment 
             | 
            (1,180,380 | ) | (1,459,196 | ) | |||||
| 
                   Proceeds
      from sale of property, plant and equipment 
             | 
            1,200 | - | |||||||
| 
               Net
      cash used in investing activities 
             | 
            (1,179,180 | ) | (1,459,196 | ) | |||||
| 
               Financing
      activities 
             | 
            |||||||||
| 
                   Net
      proceeds from (payments on) long-term debt 
             | 
            6,024,485 | (4,023,707 | ) | ||||||
| 
                   Dividends
      paid 
             | 
            (1,566,294 | ) | (927,189 | ) | |||||
| 
                   Capital
      contributed 
             | 
            - | 20,340 | |||||||
| 
                   Excess
      tax benefits from Stock Grant Plan 
             | 
            13,720 | - | |||||||
| 
                   Proceeds
      from exercised stock options 
             | 
            4,650 | 281,923 | |||||||
| 
               Net
      cash provided by (used in) financing activities 
             | 
            4,476,561 | (4,648,633 | ) | ||||||
| 
                   Decrease
      in cash and cash equivalents 
             | 
            (2,333 | ) | (19,043 | ) | |||||
| 
                   Cash
      and cash equivalents at beginning of period 
             | 
            28,269 | 21,413 | |||||||
| 
               Cash
      and cash equivalents at end of period 
             | 
            $ | 25,936 | $ | 2,370 | |||||
| 
               See
      accompanying notes to condensed consolidated financial
      statements. 
             | 
            |||||||||
| 
               Weighted 
             | 
            
               Weighted 
             | 
            |||||||||||||||||||
| 
               Average 
             | 
            
               Average 
             | 
            
               Intrinsic 
             | 
            ||||||||||||||||||
| 
               Exercise 
             | 
            
               Options 
             | 
            
               Contractual 
             | 
            
               Value
      of 
             | 
            
               Options 
             | 
            ||||||||||||||||
| 
               Price 
             | 
            
               Outstanding 
             | 
            
               Term 
             | 
            
               Options 
             | 
            
               Available 
             | 
            ||||||||||||||||
| 
               (in
      years) 
             | 
            ||||||||||||||||||||
| 
               At
      December 29, 2007 
             | 
            $ | 8.51 | 130,743 | 4.6 | $ | 1,198,000 | 207,100 | |||||||||||||
| 
                   Exercised 
             | 
            $ | 4.65 | (1,000 | ) | $ | 8,550 | ||||||||||||||
| 
               At
      March 29, 2008 
             | 
            $ | 8.54 | 129,743 | 4.4 | $ | 471,930 | 207,100 | |||||||||||||
| 
               Exercisable
      options 
             | 
            $ | 8.12 | 100,289 | 3.7 | $ | 407,131 | ||||||||||||||
| 
               Grant
      Date 
             | 
            ||||||||||||||||||||
| 
               Options
      expected to vest: 
             | 
            
               Fair
      Value 
             | 
            |||||||||||||||||||
| 
                 At
      December 29, 2007 
             | 
            $ | 9.96 | 43,454 | 7.1 | $ | 6.77 | ||||||||||||||
| 
                   Vested
      in the quarter 
             | 
            $ | 9.96 | (14,000 | ) | ||||||||||||||||
| 
                 At
      March 29, 2008 
             | 
            $ | 9.96 | 29,454 | 6.9 | $ | 6.77 | ||||||||||||||
| 
               Weighted 
             | 
            ||||||||
| 
               Average 
             | 
            ||||||||
| 
               Grant
      Date 
             | 
            ||||||||
| 
               Shares 
             | 
            
               Fair
      Value 
             | 
            |||||||
| 
               Outstanding
      at December 29, 2007 
             | 
            22,180 | $ | 25.00 | |||||
| 
               Granted 
             | 
            11,480 | $ | 16.35 | |||||
| 
               Vested 
             | 
            (4,436 | ) | $ | 25.00 | ||||
| 
               Forfeited
      or expired 
             | 
            (3,040 | ) | $ | 21.24 | ||||
| 
               Outstanding
      at March 29, 2008 
             | 
            26,184 | $ | 21.64 | |||||
| 
               Three
      Months Ended 
             | 
            ||||||||
| 
               Mar
      29, 2008 
             | 
            
               Mar
      31, 2007 
             | 
            |||||||
| 
               Net
      sales 
             | 
            ||||||||
| 
               Specialty
      Chemicals Segment 
             | 
            $ | 14,052,000 | $ | 12,445,000 | ||||
| 
               Metals
      Segment 
             | 
            36,922,000 | 31,953,000 | ||||||
| $ | 50,974,000 | $ | 44,398,000 | |||||
| 
               Segment
      income 
             | 
            ||||||||
| 
               Specialty
      Chemicals Segment 
             | 
            $ | 439,000 | $ | 607,000 | ||||
| 
               Metals
      Segment 
             | 
            3,449,000 | 5,620,000 | ||||||
| 3,888,000 | 6,227,000 | |||||||
| 
               Unallocated
      expenses 
             | 
            ||||||||
| 
               Corporate 
             | 
            744,000 | 752,000 | ||||||
| 
               Interest
      expense 
             | 
            332,000 | 209,000 | ||||||
| 
               Other
      income 
             | 
            (2,000 | ) | (1,000 | ) | ||||
| 
               Income
      before income taxes 
             | 
            $ | 2,814,000 | $ | 5,267,000 | ||||
| 
               Number
      of Shares 
             | 
            
               Aggregate
      Exercise 
             | 
            |||||||||
| 
               Date Issued 
             | 
            
               Class of Purchasers 
             | 
            
               Issued 
             | 
            
               Price 
             | 
            |||||||
| 
               2/19/2008 
             | 
            
               Officers
      and employees 
             | 
            1,000 | $ | 4,650 | ||||||
| Issuer Purchases of Equity Securities | ||||||||||||||||
| 
               | 
            
               Total
      Number 
             | 
            
               Maximum
      Number 
             | 
            ||||||||||||||
| 
               of
      Shares 
             | 
            
               of
      Shares 
             | 
            |||||||||||||||
| 
               Purchased
      as 
             | 
            
               that
      may yet be 
             | 
            |||||||||||||||
| 
               Quarter 
             | 
            
               Average 
             | 
            
               Part
      of Publically 
             | 
            
               Purchased
      Under 
             | 
            |||||||||||||
| 
               Ended
      2008 
             | 
            
               Total
      Number 
             | 
            
               Price
      Paid 
             | 
            
               Announced 
             | 
            
               the
      Plans 
             | 
            ||||||||||||
| 
               for
      the Period 
             | 
            
               of
      Shares (1) 
             | 
            
               per
      Share (1) 
             | 
            
               Plans
      or Programs 
             | 
            
               or
      Programs 
             | 
            ||||||||||||
| - | - | - | - | |||||||||||||
| 
               (1)
      This column reflects the surrender of previously owned shares of common
      stock to pay the exercise price 
             | 
            ||||||||||||||||
| 
               in
      connection with the exercise of stock options. 
             | 
            ||||||||||||||||
| 
                Item 6. 
             | 
            
               Exhibits 
             | 
          |
| 
               The
      following exhibits are included herein: 
             | 
          ||
| 
               31 
             | 
            
               Rule
      13a-14(a)/15d-14(a) Certifications of Chief Executive Officer and Chief
      Financial Officer 
               | 
          |
| 
               32 
             | 
            
               Certifications
      Pursuant to 18 U.S.C. Section 1350 
               | 
          |
| 
               SYNALLOY
      CORPORATION 
             | 
          ||
| (Registrant) | ||
| 
               Date:
      May 9, 2008 
             | 
            
               By: 
             | 
            
               /s/ Ronald H.
      Braam                  
             | 
          
| 
               Ronald
      H. Braam 
             | 
          ||
| 
               President
      and Chief Executive Officer 
             | 
          ||
| 
               Date:  May 9, 2008 
             | 
            
               By: 
             | 
            
               /s/ Gregory M.
      Bowie                    
             | 
          
| 
               Gregory
      M. Bowie 
             | 
          ||
| 
               Vice
      President Finance and Chief Financial Officer 
             | 
          ||